ProCE Banner Activity

Telemedicine: Managing Patients With CLL During the COVID-19 Pandemic

Clinical Thought
How are you using telemedicine or other strategies to manage your patients with CLL during the COVID-19 pandemic?

Released: July 13, 2020

Expiration: July 12, 2021

Share

Faculty

John Pagel

John Pagel, MD, PhD

Associate Professor
Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

John Pagel, MD, PhD

Associate Professor
Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington

John Pagel, MD, PhD, has disclosed that he has received consulting fees from AstraZeneca, BeiGene, Gilead Sciences, and Loxo.